Skip to main content
Log in

The effect of age and diabetes mellitus on serum levels of lymphotoxin

  • Published:
AGE Aims and scope Submit manuscript

Abstract

To determine whether chronic hyperglycemia or aging is associated with increased serum levels of lymphotoxin, sera were obtained from 29 insulin-treated diabetic patients and 50 healthy subjects ranging in age from 22 to 97 years old. An ELISA system specific for human lymphotoxin was developed with the lower limit of sensitivity at 76 pg/ml and interassay coefficient of variation of <7%. Serum levels of tumor necrosis factor (TNF) alpha, interleukin 1 (IL-1) alpha and beta were measured with previously described ELISA system. The WEHI 164 cytotoxicity assay was used to measure bioassayable TNF-like activity. Of the 29 diabetic patients, seven had detectable serum immunoreactive lymphotoxin levels and three had bioassayable serum levels of TNF-like activity. In contrast, only one healthy subject had detectable serum lymphotoxin levels (p<0.01). Of the 22 diabetic patients who did not have detectable levels of lymphotoxin, 5 had detectable TNFα, 4 had detectable IL-1α, and none had detectable IL-1β levels. Thus, there was no correlation between serum lymphotoxin level and serum levels of TNF α, IL-1 α, or IL-1 β. Aging is not associated with altered serum levels of lymphotoxin while 24% of diabetic patients have increased serum levels of immunoreactive lymphotoxin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sathit, P., Miller, J.E., Waldrop, S., and Khan, A.: Cellular origin of human lymphotoxin and its purification. Clin. Immunol. Immunopathol., 35: 22–34, 1985.

    Article  Google Scholar 

  2. Paul, N.L., Ruddle, and N.H., Lymphotoxin. Ann. Rev. Immunol., 6: 407–438, 1988.

    Article  CAS  Google Scholar 

  3. Mooradian, A.D., Reed, R.L., Meredith, K.E., and Scuderi, P.: Serum levels of tumor necrosis factor and IL-1α and IL-1β in diabetic patients. Diabetes Care, 14: 63–65, 1991.

    PubMed  CAS  Google Scholar 

  4. Mooradian, A.D., Reed, R.L., Osterweil, D., Schiffman, P., and Scuderi, P.: Decreased serum triiodothyronine is associated with increased concentration of tumor necrosis factor. J. Clin. Endocrinol. Metab., 71: 1239–1242, 1990.

    Article  PubMed  CAS  Google Scholar 

  5. Mooradian, A.D., Reed, R.L., Osterweil, D., Clements, N., and Scuderi, P.: Lack of an association between the presence of tumor necrosis factor or interleukin 1 alpha in the blood and weight loss among elderly patients. J. Am. Geriatr. Soc., 38: 397–401, 1990.

    PubMed  CAS  Google Scholar 

  6. Mooradian, A.D., Reed, R.A., and Scuderi, P.: Serum levels of tumor necrosis factor alpha, interleukin-1 alpha and beta in healthy elderly subjects. Age, 14: 61–64, 1991.

    Google Scholar 

  7. Morley, J.E., Mooradian, A.D., Rosenthal, M.H., and Kaiser, F.E.: Diabetes mellitus in the elderly: Is it different? Am. J. Med., 83: 533–544, 1987.

    Article  PubMed  CAS  Google Scholar 

  8. Scuderi, P., Nez, P.A., Duerr, M.L., Wong, B.J., and Valdez, C.M: Cathepsin-G and leukocyte inactivate tumor necrosis factor and lymphotoxin. Cell Imunol., 135: 299–313, 1991.

    Article  CAS  Google Scholar 

  9. Espevik, T., and Nissen-Meyer, J.: A highly sensitive cell line WEHI-164 clone 13 for measuring cytotoxic factor/TNF from human monocytes. J. Immun. Methods, 95: 99–105, 1986.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Mooradian, A.D., Reed, R.L., Duerr, M.L. et al. The effect of age and diabetes mellitus on serum levels of lymphotoxin. AGE 15, 95–99 (1992). https://doi.org/10.1007/BF02435008

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02435008

Keywords

Navigation